ArticleFrontiers in molecular neuroscience2011
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies.
Miguel Medina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this papercites it